sr 11237 has been researched along with epidermal growth factor in 1 studies
| Studies (sr 11237) | Trials (sr 11237) | Recent Studies (post-2010) (sr 11237) | Studies (epidermal growth factor) | Trials (epidermal growth factor) | Recent Studies (post-2010) (epidermal growth factor) |
|---|---|---|---|---|---|
| 26 | 0 | 9 | 24,155 | 217 | 4,699 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brocard, J; Calléja, C; Chambon, P; Chapellier, B; Gérard, C; Ghyselinck, NB; Li, M; Mark, M; Messaddeq, N; Metzger, D; Warot, X | 1 |
1 other study(ies) available for sr 11237 and epidermal growth factor
| Article | Year |
|---|---|
Physiological and retinoid-induced proliferations of epidermis basal keratinocytes are differently controlled.
Topics: Alleles; Animals; Cell Division; Crosses, Genetic; Dimerization; Epidermal Cells; Epidermal Growth Factor; Epidermis; Gene Targeting; Heparin-binding EGF-like Growth Factor; Homeostasis; Hyperplasia; Intercellular Signaling Peptides and Proteins; Keratinocytes; Mice; Mice, Knockout; Mice, Transgenic; Mutagenesis; Paracrine Communication; Protein Multimerization; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Retinoic Acid Receptor gamma; Retinoid X Receptors; Retinoids; Tamoxifen; Transcription Factors; Transcription, Genetic; Tretinoin | 2002 |